Literature DB >> 24078849

Correspondence (letter to the editor): One-sided publication.

Günther Egidi.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24078849      PMCID： PMC3784033          DOI： 10.3238/arztebl.2013.0609b

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Earlier discovery of pregabalin's dependence potential might have been possible.

Authors:  Ola Caster; I Ralph Edwards; G Niklas Norén; Marie Lindquist
Journal:  Eur J Clin Pharmacol       Date:  2010-10-23       Impact factor: 2.953

2.  A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system.

Authors:  Sofie Schwan; Anders Sundström; Elisabet Stjernberg; Ebba Hallberg; Pär Hallberg
Journal:  Eur J Clin Pharmacol       Date:  2010-06-19       Impact factor: 2.953

Review 3.  Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.

Authors:  David Baldwin; Robert Woods; Richard Lawson; David Taylor
Journal:  BMJ       Date:  2011-03-11

4.  The diagnosis and treatment of generalized anxiety disorder.

Authors:  Borwin Bandelow; Reinhard Boerner J; Siegfried Kasper; Michael Linden; Hans-Ulrich Wittchen; Hans-Jürgen Möller
Journal:  Dtsch Arztebl Int       Date:  2013-04-26       Impact factor: 5.594
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.